LncRNA, NEAT1 is a prognosis biomarker and regulates cancer progression via epithelial-mesenchymal transition in clear cell renal cell carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

LncRNA, NEAT1 is a prognosis biomarker and regulates cancer progression via epithelial-mesenchymal transition in clear cell renal cell carcinoma

Published:2017-05-06 Issue:1 Volume:19 Page:75-83
ISSN:1574-0153
Container-title:Cancer Biomarkers
language:
Short-container-title:CBM

Author:

Ning Li¹,Li Zhiguo¹,Wei Dianjun¹,Chen Haiyan²,Yang Chao³

Affiliation:

1. Department of Clinical Laboratory, The Second Hospital of Tianjin Medical University, Tianjin, China

2. Department of Nephrology, The Second Hospital of Tianjin Medical University, Tianjin, China

3. Department of Clinical Laboratory, The First Affiliated Hospital of Xi'an Medical University, Xi'an, Shaanxi, China

Publisher

IOS Press

Subject

Cancer Research,Genetics,Oncology,General Medicine

Reference33 articles.

1. The epidemiology of renal cell carcinoma;Ljungberg;Eur Urol,2011

2. Targeted therapies for renal cell carcinoma: Understanding their impact on survival;Pal;Target Oncol,2010

3. Tolerability of first-line therapy for metastatic renal cell carcinoma;Porta;Cancer Treat Rev,2009

4. Treatment of localised renal cell carcinoma;Van Poppel;Eur Urol,2011

5. Chemotherapy for advanced renal-cell carcinoma: 1983-1993;Yagoda;Semin Oncol,1995

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The regulation of hypoxia-related lncRNAs in hepatocellular carcinoma;Discover Oncology;2024-05-07

2. Identification of a pyroptosis-immune-related lncRNA signature for prognostic and immune landscape prediction in bladder cancer patients;Discover Oncology;2024-05-02

3. Exploring the role of lncrna neat1 knockdown in regulating apoptosis across multiple cancer types: A review;Pathology - Research and Practice;2023-12

4. Identification of a pyroptosis-immune-related lncRNA signature for prognostic and immune landscape prediction in bladder cancer patients;2023-10-19

5. A New Understanding of Long Non-Coding RNA in Hepatocellular Carcinoma—From m6A Modification to Blood Biomarkers;Cells;2023-09-14

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3